Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
NovaBay Pharmaceuticals, Inc. (NBY) had Current Liabilities of $2.14M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.92M |
|
-- |
|
-- |
|
$1.89M |
|
$-1.89M |
|
$-0.07M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.92M |
|
$-1.96M |
|
$-1.89M |
|
$-1.89M |
|
5.82M |
|
5.82M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$6.12M |
|
$0.01M |
|
$0.80M |
|
$6.91M |
|
|
Current Liabilities |
$2.14M |
-- |
|
$0.52M |
|
$2.67M |
|
$4.24M |
|
$4.25M |
|
$4.25M |
|
5.82M |
|
| Cash Flow Statement Financials | |
$-4.32M |
|
-- |
|
$-1.88M |
|
$0.91M |
|
$5.82M |
|
$4.91M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.85 |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.32M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-46.33% |
|
-46.27% |
|
-28.42% |
|
-46.27% |
|
$0.73 |
|
$-0.74 |
|
$-0.74 |
|